Authors:
Yoshimura, K
Hazama, S
Iizuka, N
Yoshino, S
Yamamoto, K
Muraguchi, M
Ohmoto, Y
Noma, T
Oka, M
Citation: K. Yoshimura et al., Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Ig kappa leader sequence, CANC GENE T, 8(1), 2001, pp. 9-16
Authors:
Iizuka, N
Tangoku, A
Hazama, S
Yoshino, S
Mori, N
Oka, M
Citation: N. Iizuka et al., Nm23-H1 gene as a molecular switch between the free-floating and adherent states of gastric cancer cells, CANCER LETT, 174(1), 2001, pp. 65-71
Authors:
Ohno, R
Yamaguchi, Y
Toge, T
Kinouchi, T
Kotake, T
Shibata, M
Kiyohara, Y
Ikeda, S
Fukui, I
Gohchi, A
Sugiyama, Y
Saji, S
Hazama, S
Oka, M
Ohnishi, K
Ohhashi, Y
Tsukagoshi, S
Taguchi, T
Citation: R. Ohno et al., A dose-escalation and pharmacokinetic study of subcutaneously administeredrecombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies, CLIN CANC R, 6(7), 2000, pp. 2661-2669
Authors:
Iizuka, N
Miyamoto, K
Hazama, S
Yoshino, S
Yoshimura, K
Okita, K
Fukumoto, T
Yamamoto, S
Tangoku, A
Oka, M
Citation: N. Iizuka et al., Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6, CANCER LETT, 158(1), 2000, pp. 35-41
Authors:
Iizuka, N
Miyamoto, K
Okita, K
Tangoku, A
Hayashi, H
Yosino, S
Abe, T
Morioka, T
Hazama, S
Oka, M
Citation: N. Iizuka et al., Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines, CANCER LETT, 148(1), 2000, pp. 19-25
Authors:
Yoshino, S
Tabata, T
Hazama, S
Iizuka, N
Yamamoto, K
Hirayama, M
Tangoku, A
Oka, M
Citation: S. Yoshino et al., Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers, ANTICANC R, 20(6C), 2000, pp. 4707-4711
Authors:
Yamaguchi, H
Yamauchi, H
Hazama, S
Hamamoto, H
Citation: H. Yamaguchi et al., Evaluation of body fluid status after cardiac surgery using bioelectrical impedance analysis, J CARD SURG, 41(4), 2000, pp. 559-566
Authors:
Iizuka, N
Miyamoto, K
Tangoku, A
Hayashi, H
Hazama, S
Yoshino, S
Yoshimura, K
Hirose, K
Yoshida, H
Oka, M
Citation: N. Iizuka et al., Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na+, K+-ATPase, BR J CANC, 83(9), 2000, pp. 1209-1215
Authors:
Mori, N
Oka, M
Hazama, S
Lizuka, N
Yamamoto, K
Yoshino, S
Tangoku, A
Noma, T
Hirose, K
Citation: N. Mori et al., Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads, BR J CANC, 83(8), 2000, pp. 1026-1032
Authors:
Yamaguchi, H
Yamauchi, H
Hazama, S
Hamamoto, H
Inoue, N
Citation: H. Yamaguchi et al., Correlation between cerebral oxygen metabolism and cerebral blood flow simultaneously measured before and after acetazolamide administration, J BIOMED OP, 4(4), 1999, pp. 418-423
Authors:
Iizuka, N
Hazama, S
Hirose, K
Abe, T
Tokuda, N
Fukumoto, T
Tangoku, A
Oka, M
Citation: N. Iizuka et al., Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma, CANCER LETT, 142(2), 1999, pp. 179-184
Authors:
Oka, M
Hazama, S
Takahashi, M
Yamamoto, K
Abe, T
Yoshino, S
Hayashi, H
Tangoku, A
Citation: M. Oka et al., Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus, HEP-GASTRO, 46(28), 1999, pp. 2254-2259
Citation: K. Hirazawa et al., Depressed cytotoxic activity of hepatic nonparenchymal cells in rats with obstructive jaundice, SURGERY, 126(5), 1999, pp. 900-907
Authors:
Iizuka, N
Hirose, K
Noma, T
Hazama, S
Tangoku, A
Hayashi, H
Abe, T
Yamamoto, K
Oka, M
Citation: N. Iizuka et al., The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma, BR J CANC, 81(3), 1999, pp. 469-475
Authors:
Hazama, S
Noma, T
Wang, F
Iizuka, N
Ogura, Y
Yoshimura, K
Inoguchi, E
Hakozaki, M
Hirose, K
Suzuki, T
Oka, M
Citation: S. Hazama et al., Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo, BR J CANC, 80(9), 1999, pp. 1420-1426
Citation: T. Tabata et al., Th2 subset dominance among peripheral blood T lymphocytes in patients withdigestive cancers, AM J SURG, 177(3), 1999, pp. 203-208